Metastatic Soft Tissue Sarcoma
Showing 1 - 14 of 14
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,
Recruiting
- Metastatic Bone Sarcoma
- +5 more
- Cisplatin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 24, 2023
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)
Recruiting
- Metastatic Soft Tissue Sarcoma
- Advanced Soft Tissue Sarcoma
- doxorubicin with AGEN1884 and AGEN2034
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 4, 2023
Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor
Active, not recruiting
- Locally Advanced Bone Sarcoma
- +20 more
- Ipilimumab
- +3 more
-
Anchorage, Alaska
- +650 more
Oct 18, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle
Recruiting
- Advanced Soft Tissue Sarcoma
- +2 more
- Nanoparticle Albumin-Bound Rapamycin
- Pazopanib hydrochloride
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +
Recruiting
- Metastatic Esophageal
- +7 more
- LVGN3616 + LVGN6051 + Nab-Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)
Recruiting
- Advanced Soft Tissue Sarcoma
- Metastatic Soft Tissue Sarcoma
- Trabectedin
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Research Center
May 4, 2022
Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United
Recruiting
- Metastatic Leiomyosarcoma
- +10 more
- Cabozantinib
- +3 more
-
Duarte, California
- +4 more
Nov 4, 2021
Metastatic Soft Tissue Sarcoma Trial in France (Regorafenib, Placebo)
Recruiting
- Metastatic Soft Tissue Sarcoma
- Regorafenib
- Placebo
-
Besançon, France
- +19 more
Dec 8, 2020
Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 Trial in Seattle (procedure, other, drug)
Withdrawn
- Myxoid Liposarcoma
- +5 more
- Biopsy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2019
Metastatic Soft Tissue Sarcoma Trial in Worldwide (MORAb-004, Gemcitabine, Docetaxel)
Completed
- Metastatic Soft Tissue Sarcoma
- MORAb-004
- +3 more
-
Santa Monica, California
- +28 more
Aug 1, 2019
Metastatic Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Worldwide
Unknown status
- Metastatic Soft Tissue Sarcoma
- +2 more
-
Santa Monica, California
- +33 more
Sep 12, 2013